Resources from the same session
Integrating CDK4-6 inhibitors in patients with early HR positive / HER2 negative breast cancer: Successes and failures
Presenter: M. Gnant, AT
Session: Session 1 - CDK4-6 inhibitors in breast cancer
Resources:
Slides
Webcast
Risk stratification in HR positive / HER2 negative early breast cancer: Lessons from neoadjuvant and adjuvant setting
Presenter: Ana Bosch, SE
Session: Session 1 - CDK4-6 inhibitors in breast cancer
Resources:
Slides
Webcast